P7C3-OMe
P7C3-OMe is a pro-neurogenic compound, has therapeutic benefits in neuropsychiatric and/or neurodegenerative disease. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer[1].
Product Specifications
CAS Number
[313268-18-7]
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/1-3-6-dibromocarbazol-9-yl-3-3-methoxyanilino-propan-2-ol.html
Purity
98.26
Solubility
DMSO : ≥ 100 mg/mL
Smiles
OC(CNC1=CC=CC(OC)=C1)CN2C3=C(C4=C2C=CC(Br)=C4)C=C(Br)C=C3
Molecular Formula
C22H20Br2N2O2
Molecular Weight
504.21
References & Citations
[1]Pieper AA, et al. Discovery of a proneurogenic, neuroprotective chemical. Cell. 2010 Jul 9;142 (1) :39-51.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Mertk (Tyrosine-Protein Kinase Mer, Proto-Oncogene c-Mer, Receptor Tyrosine Kinase MerTK, Mertk, Mer) (Biotin) discontinued